The startup has the only FDA authorization for direct-to-consumer genetic tests.23andMe, the genetic testing startup created and led by co-founder and CEO Anne Wojcicki, just landed $250 million.The financing brings the total capital raised by 23andMe to $491 million. Wojcicki plans to put the new funds to work on growing the company and to further invest in 23andMes research platform.New investor Sequoia Capital led the funding. New investors Euclidean Capital, Altimeter Capital and the Wallenberg Foundation joined, as did current investors Fidelity Management & Research Company, lead investor for 23andMe’s prior financing round, and Casdin Capital.

Source: Click here

Share this article

Facebook Comments